BioSpace News Archive

Business

Sanofi and Denali Partner on Small Molecule Development in Potential $1 Billion Deal

Shares of Denali Therapeutics are up more than 10 percent in premarket trading after the company announced it has inked a collaborative deal with Sanofi to develop potential treatments for neurological and systemic inflammatory diseases.

November 1, 2018
·
3 min read
·
Alex Keown
FDA

FDA Approves Humira Biosimilar That Won’t Be Available Until 2023

The U.S. Food and Drug Administration (FDA) gave the green light to Hyrimoz, a biosimilar to AbbVie’s blockbuster drug Humira, five years ahead of the time it can be launched in U.S. markets.

November 1, 2018
·
2 min read
·
Alex Keown
Drug Development

Intellia’s CRISPR Trial Delay Raises Questions About Immune Responses

In its recent third-quarter report, Cambridge, Mass.-based Intellia Therapeutics indicated it is delaying its submission of an Investigational New Drug (IND) application until 2020, from late 2019.

November 1, 2018
·
3 min read
·
Mark Terry
Policy

Tainted Blood Pressure Drugs Causes FDA to Issue Recall Alert

The U.S. Food and Drug Administration issued a voluntary recall of a medication to treat high blood pressure due to trace amounts of a carcinogen being found within some lots of the drug.

November 1, 2018
·
2 min read
·
Alex Keown
Drug Development

November 2 Research Roundup: Skinny Mice, Why Weed Affects Women Differently Than Men, and How a Virus Kills Cancer Cells

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

November 1, 2018
·
7 min read
·
Mark Terry
Deals

Illumina Acquires Pacific Biosciences for $1.2 Billion

The deal to acquire its rival, Pacific Biosciences, will provide Illumina with a more comprehensive sequencing test at a lower cost.

November 1, 2018
·
2 min read
·
Alex Keown
Drug Development

People Who’ve Had Appendectomies Have 19% Lower Risk of Parkinson’s Disease

Researchers from Van Andel Research Institute, based in Grand Rapids, Mich., found that people who had appendicitis resulting in the removal of the organ, had a lower risk of developing Parkinson’s disease later in life.

November 1, 2018
·
3 min read
·
Mark Terry
Drug Development

Half of U.K. Clinical Trials Fail to Publish Data, Report Shows

The United Kingdom is calling for greater clinical trial transparency after a government committee released a report that indicates that data from about half of all clinical trials in that country are not published, raising concerns over research integrity and risks to human health.

November 1, 2018
·
2 min read
·
Alex Keown
Business

Roche and AbbVie Push Towards First-Line CLL Treatment

A study evaluated fixed-duration the two companies’ Venclexta/Venclyxto (venetoclax) in combination with Genentech’s Gazyva/Gazyvaro (obinutuzumab) in patients with previously untreated chronic lymphocytic leukemia (CLL) and co-existing medical conditions.

November 1, 2018
·
3 min read
·
Mark Terry
Biotech Beach

First Marijuana-Based Medicine for Epilepsy Now Available in the U.S.

GW Pharmaceuticals, with offices in London, UK and Carlsbad, Calif., announced that its Epidiolex (cannabidiol) for seizures associated with Lennox-Gastaut syndrome (LGS) or Draven syndrome is now available in the United States.

November 1, 2018
·
3 min read
·
Mark Terry